Form C-AR — Deverra Therapeutics, Inc.
0001822782-26-000003 · filed May 6, 2026
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1822782
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 2033 6th Ave Suite 600
Seattle, WA 28121 - Phone
- —
Most recent fiscal year financials
- Total assets
- $10,077,334
- Cash
- —
- Short-term debt
- $1,435,000
- Long-term debt
- $102,916
- Revenues
- $696,727
- COGS
- $696,727
- Taxes paid
- —
- Net income
- $-1,523,035
View the original filing on SEC EDGAR ↗